Crohns & Colitis Foundation Perspectives

Host: Caren Heller, MD Guest: Francis Farraye, MD Studies have shown that certain patients living with inflammatory bowel disease, or IBD, have a higher risk of developing colorectal cancer. In fact, IBD ranks as the third highest risk factor for the development of colorectal cancer. Host Dr. Caren Heller, Chief Scientific Officer at the Crohn's & Colitis Foundation, sits down with Dr. Francis Farraye, gastroenterologist and Professor of Medicine and Co-Director of the Center for Digestive Disorders at Boston University School of Medicine. The two talk about making guidelines on endoscopic screening, surveillance, and detection of dysplasia more beneficial to IBD patients.

Host: Caren Heller, MD Guest: Christina Ha, MD, FACG, AGAF Dr. Caren Heller, Chief Scientific Officer at the Crohn’s & Colitis Foundation chats with Dr. Christina Ha, Assistant Clinical Professor of Gastroenterology at the University of California-Los Angeles about what physicians need to know regarding extraintestinal findings in IBD.

Host: Lea Ann Chen, MD Guest: Miguel Regueiro, MD, AGAF Recorded on location at the Crohn’s & Colitis Foundation’s Annual Meeting in Orlando, host Dr. Lea Ann Chen, Assistant Professor of Medicine at New York University, discusses surgical indications for the IBD patient with Dr. Miguel Regueiro, Professor of Medicine at the University of Pittsburgh.

Predictors of Emergency Department Use by Persons with Inflammatory Bowel Diseases: A Population-based Study Nugent, Zoann PhD; Singh, Harminder MD, MPH; Targownik, Laura E. MD; Strome, Trevor MS; Snider, Carolyn MD, MPH; Bernstein, Charles N. MD Background: To describe the patterns and predictors of emergency department (ED) attendance and post-ED hospitalization by persons with inflammatory bowel disease (IBD). Methods: We linked the University of Manitoba IBD Epidemiology Database with the Emergency Department Information System of the Winnipeg Regional Health Authority to determine the rates of presentation to the ED by persons with IBD from January 01, 2009 to March 31, 2012. Incident cases were diagnosed during the study period and all others were considered prevalent cases. Multivariate logistic regression was used to determine predictors of attendance in the ED and for hospitalization within 2 days of ED attendance. Results: The study population included 300 incident and 3394 prevalent IBD cases, of w

Host: Laura Wingate Guest: Jason Ken Hou, MD, MS, FACG Patients with inflammatory bowel diseases (IBD) are at a greater risk of developing anemia, a common complication that affects their quality of life and is associated with high rates of other IBD-related complications. Host Laura Wingate, Vice President of Education, Support and Advocacy for the Crohn's & Colitis Foundation, chats with Dr. Jason Hou, Assistant Professor of Gastroenterology at Baylor College of Medicine about gaps in the importance of anemia management, diagnostics, and awareness for patients with IBD that continue to exist among healthcare providers.

Host: Caren Heller, MD Guest: Adam S. Cheifetz, MD Severe ulcerative colitis continues to cause frequent medical emergencies requiring hospitalization for optimal management. Host Dr. Caren Heller, Chief Scientific Officer at the Crohn's & Colitis Foundation, discusses several medical rescue therapies for severe ulcerative colitis in the hospital setting with Dr. Adam Cheifetz, Associate Professor of Medicine at Beth Israel Deaconess Medical Center.

Guest: KT Park, MD Recorded on location at the Crohn’s & Colitis Foundation's Annual Meeting in Orlando, host Dr. Sophie Balzora, Crohn's & Colitis Foundation Reach-IBD member and faculty advisor of the Greater New York Chapter Fellows' Education Committee, discusses general strategies for clinicians and families to optimize growth in pediatric IBD with Dr. K.T. Park, Assistant Professor of Pediatric Gastroenterology at Stanford University School of Medicine & Co-Director of Stanford Children’s Inflammatory Bowel Disease Center.

Host: Lea Ann Chen, MD Guest: Gary Lichtenstein, MD Recorded on location at the Crohn’s & Colitis Foundation’s Annual Meeting in Orlando, host Dr. Lea Ann Chen, Assistant Professor of Medicine at New York University, discusses potential complications of biologics with Dr. Gary Lichtenstein, Professor of Medicine at the Hospital of the University of Pennsylvania.

Guest: Gil Melmed, MD Recorded on location at the Crohn’s & Colitis Foundation's Annual Meeting in Orlando, host Laura Wingate,Vice President of Education Support and Advocacy for the Crohn's & Colitis Foundation, discusses health maintenance for IBD patients with Dr. Gil Melmed, Director of the Advanced IBD Fellowship Program and Clinical Research in the Division of Gastroenterology at Cedars-Sinai Medical Center.

Host: Lea Ann Chen, MD Guest: Hans Herfarth, MD Recorded on location at the Crohn’s & Colitis Foundation’s Annual Meeting in Orlando, host Dr. Lea Ann Chen, Assistant Professor of Medicine at New York University, discusses goals of therapy in IBD with Dr. Hans Herfarth, Professor of Medicine at University of North Carolina School of Medicine.

Host: Caren Heller, MD Guest: William J. Sandborn, MD Clinical trials, among several critical purposes, are essential for the evaluation and approval of medication options for patients living with inflammatory bowel diseases. Despite this, only 6% of clinical trials are completed on time due to unfulfilled enrollment, often stemming to communication barriers between clinicians and patients. Host Dr. Caren Heller, Chief Scientific Officer at the Crohn's & Colitis Foundation, sits down with Dr. William Sandborn, Professor of Medicine and Adjunct Professor of Surgery at the University of California-San Diego, about the many benefits that clinical trials can provide for IBD patients.

From the Crohn's & Colitis Foundation's Take Steps Walk in Philadelphia, host Rhondell Domilici talks with Dr. Lindsey Albenberg, Gastroenterologist in the division of Gastroenterology, Hepatology and Nutrition at the Children's Hospital of Philadelphia, about the value of nutrition in managing inflammatory bowel disease.

Impact of Specialized Inpatient IBD Care on Outcomes of IBD Hospitalizations: A Cohort Study Law, Cindy C. Y. MD; Sasidharan, Saranya MD; Rodrigues, Rodrigo MD; Nguyen, Deanna D. MD; Sauk, Jenny MD; Garber, John MD; Giallourakis, Cosmas MD; Xavier, Ramnik MD, PhD; Khalili, Hamed MD, MPH; Yajnik, Vijay MD, PhD; Ananthakrishnan, Ashwin N. MD, MPH Host: Dr. Manish Singla, Gastroenterology Division, Department of Internal Medicine, Walter Reed National Military Medical Center, Bethesda, MD Background: The management of inflammatory bowel diseases (IBDs; Crohn's disease, ulcerative colitis) is increasingly complex. Specialized care has been associated with improved ambulatory IBD outcomes. Aims: To examine if the implementation of specialized inpatient IBD care modified short-term and long-term clinical outcomes in IBD-related hospitalizations. Methods: This retrospective cohort study included IBD patients hospitalized between July 2013 and April 2015 at a single tertiary referral center where a specialized inpat

From the Crohn's & Colitis Foundation's Take Steps Walk in Philadelphia, host Rhondell Domilici talks with Jonathan Hoffman, Board Member of Crohn's & Colitis Foundation's Philadelphia Chapter, about his experience living with IBD.

From the Crohn's & Colitis Foundation's Take Steps Walk in Philadelphia, host Rhondell Domilici talks with Dr. Judith Kelsen, attending physician in the Division of Gastroenterology, Hepatology and Nutrition at the Children's Hospital of Philadelphia, about Crohn's Disease and Ulcerative Colitis in the pediatric population, and the latest research in IBD from this field.

Guest: Michael E. Kwiatt, MD From the Crohn's & Colitis Foundation's Take Steps walk in Philadelphia, host Rhondell Domilici talks with Dr. Michael Kwiatt, a surgeon at Cooper University Health Care, about the indications and benefits of surgery for patients with Inflammatory Bowel Disease.